- ESPR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Esperion Therapeutics (ESPR) S-3Shelf registration
Filed: 22 Dec 14, 12:00am
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in this Registration Statement (Form S-3) and related Prospectus of Esperion Therapeutics, Inc. for the registration of common stock, preferred stock, debt securities, warrants and units of Esperion Therapeutics, Inc. and to the incorporation by reference therein of our report dated March 13, 2014, with respect to the financial statements of Esperion Therapeutics, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2013, filed with the Securities and Exchange Commission.
| /s/ Ernst & Young LLP |
|
|
Detroit, Michigan |
|
December 22, 2014 |
|
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.